{"organizations": [], "uuid": "7944b8c116abd3f44cf984f913f0e1c23e0f8cc0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-q4-earning/brief-novabay-pharmaceuticals-q4-earnings-per-share-0-05-idUSASC09T1Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Novabay Pharmaceuticals Q4 Earnings Per Share $0.05", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T22:23:00.000+02:00", "replies_count": 0, "uuid": "7944b8c116abd3f44cf984f913f0e1c23e0f8cc0"}, "author": "", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-q4-earning/brief-novabay-pharmaceuticals-q4-earnings-per-share-0-05-idUSASC09T1Z", "ord_in_thread": 0, "title": "BRIEF-Novabay Pharmaceuticals Q4 Earnings Per Share $0.05", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-novabay pharmaceuticals", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novabay pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 20, 2018 / 8:25 PM / Updated 8 minutes ago BRIEF-Novabay Pharmaceuticals Q4 Earnings Per Share $0.05 Reuters Staff March 20 (Reuters) - Novabay Pharmaceuticals Inc: * NOVABAY PHARMACEUTICALS REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS * Q4 SALES $6.3 MILLION VERSUS I/B/E/S VIEW $6 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.04 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-20T22:23:00.000+02:00", "crawled": "2018-03-20T22:35:46.012+02:00", "highlightTitle": ""}